ABBOTT LABORATORIES — Director's Dealing 2008

Feb 14, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-12

Reporting Person: Fussell Stephen R (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-02-12	Common shares without par value	M	28485	$42.4978	Acquired	131628	Direct
2008-02-12	Common shares without par value	M	1993	$43.25	Acquired	133621	Direct
2008-02-12	Common shares without par value	F	25300	$56.34	Disposed	108321	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-02-12	Option (right to buy)	$42.4978	M	28485	Disposed	2009-02-11	common shares (28485)	Direct
2008-02-12	Option (right to buy)	$43.25	M	1993	Disposed	2010-02-10	common shares (1993)	Direct
2008-02-12	Option (right to buy)	$56.34	A	23617	Acquired	2009-02-11	common shares (23617)	Direct
2008-02-12	Option (right to buy)	$56.34	A	1683	Acquired	2010-02-10	common shares (1683)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1301	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 11, 2008.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.